Cold Atmospheric Pressure Plasma-Activated Medium Modulates Cellular Functions of Human Mesenchymal Stem/Stromal Cells In Vitro
-
Published:2024-05-01
Issue:9
Volume:25
Page:4944
-
ISSN:1422-0067
-
Container-title:International Journal of Molecular Sciences
-
language:en
-
Short-container-title:IJMS
Author:
Hahn Olga1, Waheed Tawakalitu Okikiola1, Sridharan Kaarthik1, Huemerlehner Thomas1ORCID, Staehlke Susanne1ORCID, Thürling Mario2, Boeckmann Lars3ORCID, Meister Mareike4, Masur Kai4ORCID, Peters Kirsten1ORCID
Affiliation:
1. Institute of Cell Biology, Rostock University Medical Center, 18057 Rostock, Germany 2. Microfluidics, Faculty of Mechanical Engineering and Marine Technology, University of Rostock, 18059 Rostock, Germany 3. Clinic and Polyclinic for Dermatology and Venerology Rostock, Rostock University Medical Center, 18057 Rostock, Germany 4. Leibniz-Institute for Plasma Science and Technology e.V., 17489 Greifswald, Germany
Abstract
Cold atmospheric pressure plasma (CAP) offers a variety of therapeutic possibilities and induces the formation of reactive chemical species associated with oxidative stress. Mesenchymal stem/stromal cells (MSCs) play a central role in tissue regeneration, partly because of their antioxidant properties and ability to migrate into regenerating areas. During the therapeutic application, MSCs are directly exposed to the reactive species of CAP. Therefore, the investigation of CAP-induced effects on MSCs is essential. In this study, we quantified the amount of ROS due to the CAP activation of the culture medium. In addition, cell number, metabolic activity, stress signals, and migration were analyzed after the treatment of MSCs with a CAP-activated medium. CAP-activated media induced a significant increase in ROS but did not cause cytotoxic effects on MSCs when the treatment was singular and short-term (one day). This single treatment led to increased cell migration, an essential process in wound healing. In parallel, there was an increase in various cell stress proteins, indicating an adaptation to oxidative stress. Repeated treatments with the CAP-activated medium impaired the viability of the MSCs. The results shown here provide information on the influence of treatment frequency and intensity, which could be necessary for the therapeutic application of CAP.
Funder
European Union and the Federal State Mecklenburg-Vorpommern
Reference87 articles.
1. Duarte, S., and Panariello, B.H.D. (2020). Comprehensive biomedical applications of low temperature plasmas. Arch. Biochem. Biophys., 693. 2. ROS from Physical Plasmas: Redox Chemistry for Biomedical Therapy;Schmidt;Oxid. Med. Cell. Longev.,2019 3. How mitochondria produce reactive oxygen species;Murphy;Biochem. J.,2009 4. Kalghatgi, S., Kelly, C.M., Cerchar, E., Torabi, B., Alekseev, O., Fridman, A., Friedman, G., and Azizkhan-Clifford, J. (2011). Effects of non-thermal plasma on mammalian cells. PLoS ONE, 6. 5. Mumtaz, S., Khan, R., Rana, J.N., Javed, R., Iqbal, M., Choi, E.H., and Han, I.H. (2023). Review on the Biomedical and Environmental Applications of Nonthermal Plasma. Catalysts, 13.
|
|